Skip links

Ensuring Safer Digital Payments for a FinTech

Jump To Section

Fintech survival requires rapid innovation within a complex, highly regulated environment.

A unified governance, risk, and compliance (GRC) engine replaces siloed applications and fragmented processes.

Fintech survival requires rapid innovation within a complex, highly regulated environment. For this global digital leader, Altimetrik created a scalable, extensible end-to-end GRC system that keeps pace with changing regulations across countries, and also helped implement a unified workflow process that prevents slowdowns during the launch of innovative consumer products.

  • Rolled Out in 26 Countries Within 2 Months of Production Install
  • 35% Reduction in Total Cost of Operations
  • 29% Reduction in Average Effort of Managing a Compliance Case
  • 40% Reduction in Turnaround Time for Compliance Cases

Efficient execution and rigorous engineering practices ensure safer digital payments.

Our client required an extremely rapid agile implementation to replace the most inflexible components of their legacy application while, at the same time, ensuring that business could continue without interruption.

The new system went live in record time, and all applications were decommissioned, resulting in a 35% reduction in the total cost of operations. With a more scalable and integrated compliance system, the client can now pursue product launches, modernization, and new market expansion plans with greater efficiency and without creating compliance bottlenecks.

To bring the new system to life, Altimetrik:

  • Automated analysis to rapidly create a prioritized product backlog worklist
  • Set aggressive goals for the time-to-market and quality of product
  • Created a comprehensive plan that includes continuous KPI reviews
  • Automated data quality checks, adopted principles of DevOps with automated pipelines, and leveraged use of reusable components for UI and server-side implementations

“In times when data privacy and regulatory compliance are becoming increasingly stringent, an overarching view of data security and risk across multiple platforms and domains goes a long way to ensuring that threats of compliance gaps are eliminated and result in consistently safe consumer experiences.”

Debabrata Das

Client Partner



Latest Reads


Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes